Cargando…

ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes

BACKGROUND: Individuals with type 1 diabetes (T1D) have a two- to threefold increase in fracture risk at any site, and up to a sevenfold increase in hip fracture risk compared to those without diabetes. Reduced bone quality appears to contribute to the increased fracture risk observed in this popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Coll, Julie-Catherine, Garceau, Élodie, Leslie, William D, Michou, Laëtitia, John Weisnagel, S, Mac-Way, Fabrice, Morin, Suzanne N, Rabasa-Lhoret, Rémi, Gagnon, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624666/
http://dx.doi.org/10.1210/jendso/bvac150.368
_version_ 1784822289271881728
author Coll, Julie-Catherine
Garceau, Élodie
Leslie, William D
Michou, Laëtitia
John Weisnagel, S
Mac-Way, Fabrice
Morin, Suzanne N
Rabasa-Lhoret, Rémi
Gagnon, Claudia
author_facet Coll, Julie-Catherine
Garceau, Élodie
Leslie, William D
Michou, Laëtitia
John Weisnagel, S
Mac-Way, Fabrice
Morin, Suzanne N
Rabasa-Lhoret, Rémi
Gagnon, Claudia
author_sort Coll, Julie-Catherine
collection PubMed
description BACKGROUND: Individuals with type 1 diabetes (T1D) have a two- to threefold increase in fracture risk at any site, and up to a sevenfold increase in hip fracture risk compared to those without diabetes. Reduced bone quality appears to contribute to the increased fracture risk observed in this population. Advanced glycation end products (AGEs) tissue accumulation, which reflects long-term glycemic control, may influence bone quality in T1D. OBJECTIVE: We aimed to determine if skin AGEs, as a surrogate marker for bone AGEs, are associated with vertebral trabecular bone score (TBS),anindex of bone microarchitecture derived from lumbar spine dual-energy X-ray absorptiometry (DXA) images and evaluating bone quality. METHODS: We present preliminary data from subjects with T1D who participated in a cross-sectional study aiming at comparing the prevalence of vertebral fractures between adult subjects with T1D from two tertiary care centers and age-, sex- and BMI-matched controls without diabetes. TBS and bone mineral density (BMD) were assessed using DXA. Skin AGEs were measured by skin autofluorescence. Simple and multiple linear regression analyses were used to explore the factors associated with TBS. RESULTS: One hundred and six subjects with T1D (52.8% women; mean age 42.7±14.7 years; mean BMI 26.9±5.6 kg/m 2; mean diabetes duration 27.6±12.3 years; 48.1% with a microvascular complication; mean HbA 1C in the preceding 3 years 7.5±0.9%; mean skin AGEs 2.15±0.54 units; mean TBS 1.428±0.113) were included. Higher skin AGEs were associated with a lower TBS in simple regression analysis (p=0. 012). In multiple linear regression, older age, male sex, higher BMI, current smoking, higher serum calcium, lower lumbar spine and femoral neck BMD, but not skin AGEs, were significantly associated with a lower TBS (model adjusted R 2 =0.65). CONCLUSION: In this population with relatively well-controlled T1D, skin AGEs were not independently associated with TBS. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9624666
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96246662022-11-14 ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes Coll, Julie-Catherine Garceau, Élodie Leslie, William D Michou, Laëtitia John Weisnagel, S Mac-Way, Fabrice Morin, Suzanne N Rabasa-Lhoret, Rémi Gagnon, Claudia J Endocr Soc Bone & Mineral Metabolism BACKGROUND: Individuals with type 1 diabetes (T1D) have a two- to threefold increase in fracture risk at any site, and up to a sevenfold increase in hip fracture risk compared to those without diabetes. Reduced bone quality appears to contribute to the increased fracture risk observed in this population. Advanced glycation end products (AGEs) tissue accumulation, which reflects long-term glycemic control, may influence bone quality in T1D. OBJECTIVE: We aimed to determine if skin AGEs, as a surrogate marker for bone AGEs, are associated with vertebral trabecular bone score (TBS),anindex of bone microarchitecture derived from lumbar spine dual-energy X-ray absorptiometry (DXA) images and evaluating bone quality. METHODS: We present preliminary data from subjects with T1D who participated in a cross-sectional study aiming at comparing the prevalence of vertebral fractures between adult subjects with T1D from two tertiary care centers and age-, sex- and BMI-matched controls without diabetes. TBS and bone mineral density (BMD) were assessed using DXA. Skin AGEs were measured by skin autofluorescence. Simple and multiple linear regression analyses were used to explore the factors associated with TBS. RESULTS: One hundred and six subjects with T1D (52.8% women; mean age 42.7±14.7 years; mean BMI 26.9±5.6 kg/m 2; mean diabetes duration 27.6±12.3 years; 48.1% with a microvascular complication; mean HbA 1C in the preceding 3 years 7.5±0.9%; mean skin AGEs 2.15±0.54 units; mean TBS 1.428±0.113) were included. Higher skin AGEs were associated with a lower TBS in simple regression analysis (p=0. 012). In multiple linear regression, older age, male sex, higher BMI, current smoking, higher serum calcium, lower lumbar spine and femoral neck BMD, but not skin AGEs, were significantly associated with a lower TBS (model adjusted R 2 =0.65). CONCLUSION: In this population with relatively well-controlled T1D, skin AGEs were not independently associated with TBS. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9624666/ http://dx.doi.org/10.1210/jendso/bvac150.368 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Bone & Mineral Metabolism
Coll, Julie-Catherine
Garceau, Élodie
Leslie, William D
Michou, Laëtitia
John Weisnagel, S
Mac-Way, Fabrice
Morin, Suzanne N
Rabasa-Lhoret, Rémi
Gagnon, Claudia
ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes
title ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes
title_full ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes
title_fullStr ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes
title_full_unstemmed ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes
title_short ODP127 Trabecular Bone Score and Advanced Glycation End Products In Adults with Type 1 Diabetes
title_sort odp127 trabecular bone score and advanced glycation end products in adults with type 1 diabetes
topic Bone & Mineral Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624666/
http://dx.doi.org/10.1210/jendso/bvac150.368
work_keys_str_mv AT colljuliecatherine odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes
AT garceauelodie odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes
AT lesliewilliamd odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes
AT michoulaetitia odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes
AT johnweisnagels odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes
AT macwayfabrice odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes
AT morinsuzannen odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes
AT rabasalhoretremi odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes
AT gagnonclaudia odp127trabecularbonescoreandadvancedglycationendproductsinadultswithtype1diabetes